1. Home
  2. Author
  3. Atsmon J

Atsmon J

References (2)

Title : Preclinical and first-in-human evaluation of PRX-105, a PEGylated, plant-derived, recombinant human acetylcholinesterase-R - Atsmon_2015_Toxicol.Appl.Pharmacol_287_202
Author(s) : Atsmon J , Brill-Almon E , Nadri-Shay C , Chertkoff R , Alon S , Shaikevich D , Volokhov I , Haim KY , Bartfeld D , Shulman A , Ruderfer I , Ben-Moshe T , Shilovitzky O , Soreq H , Shaaltiel Y
Ref : Toxicol Appl Pharmacol , 287 :202 , 2015
Abstract : Atsmon_2015_Toxicol.Appl.Pharmacol_287_202
ESTHER : Atsmon_2015_Toxicol.Appl.Pharmacol_287_202
PubMedSearch : Atsmon_2015_Toxicol.Appl.Pharmacol_287_202
PubMedID: 26051873

Title : Is rivastigmine safe as pretreatment against nerve agents poisoning? A pharmacological, physiological and cognitive assessment in healthy young adult volunteers - Lavon_2015_Neurotoxicol_49_36
Author(s) : Lavon O , Eisenkraft A , Blanca M , Raveh L , Ramaty E , Krivoy A , Atsmon J , Grauer E , Brandeis R
Ref : Neurotoxicology , 49 :36 , 2015
Abstract : Lavon_2015_Neurotoxicol_49_36
ESTHER : Lavon_2015_Neurotoxicol_49_36
PubMedSearch : Lavon_2015_Neurotoxicol_49_36
PubMedID: 26001567